Loading...

Qiagen N.V.

QGENNYSE
Healthcare
Medical - Diagnostics & Research
$51.07
$0.09(0.18%)

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.8/100

Key Financials

Market Cap11.1B
P/E Ratio119.26
EPS (TTM)$0.42
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Week$47.26
1 Month$41.47
3 Months$44.61
1 Year Target$46.19

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $46.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 119.26 and a market capitalization of 11.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;